- Benefit limited to AC/CC genotypes
- 19% diabetes risk reduction
- No benefit in AA genotype
- ApaI genotype predicts response
- Supports precision prevention approach
Source: JAMA Network Open
Source: JAMA Network Open
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.